pneumonia
lower
respiratori
tract
diseas
usual
caus
infecti
agent
result
inflamm
tissu
one
lung
pneumonia
develop
countri
occur
million
new
case
result
million
prevent
death
year
morbid
mortal
rate
communityacquir
pneumonia
cap
among
children
unit
state
consider
less
outpati
pediatr
visit
rate
cap
us
rang
per
children
case
per
children
year
age
rate
hospit
us
acut
pneumonia
decreas
per
children
year
age
follow
univers
conjug
pneumococc
vaccin
overal
mortal
acut
pneumonia
us
children
depend
factor
includ
age
race
socioeconom
statu
geograph
region
us
lower
respiratori
infect
lri
occur
throughout
year
excess
fall
winter
children
confin
indoor
result
effici
spread
infect
contact
droplet
transmiss
multipl
factor
predispos
acquisit
lri
daycar
school
attend
indoor
crowd
passiv
exposur
smoke
lack
underimmun
alcohol
abus
adolesc
caus
aspir
pneumonia
underli
medic
condit
low
birth
weight
bronchopulmonari
dysplasia
asthma
heart
diseas
seizur
neuromuscular
ill
gastroesophag
reflux
diseas
malnutrit
immunocompromis
state
sickl
cell
diseas
cystic
fibrosi
addit
risk
factor
associ
pneumonia
children
year
age
includ
frequent
upper
respiratori
tract
infect
uri
episod
month
wheez
age
histori
otiti
media
requir
tympanocentesi
year
age
risk
factor
pneumonia
children
year
age
includ
wheez
age
episod
uri
within
month
multipl
microb
predominantli
virus
bacteria
caus
lri
infant
children
true
preval
pathogen
caus
lri
uncertain
microbi
etiolog
ascertain
infrequ
owe
difficulti
differenti
infect
colon
lack
depend
diagnost
laboratori
test
two
studi
immunocompet
children
pneumonia
specif
etiolog
agent
confirm
case
one
pathogen
identifi
make
assign
etiolog
difficult
confirm
etiolog
bacteri
pneumonia
challeng
coexist
bacteria
pathogen
well
normal
upper
respiratori
tract
flora
occurr
bacteremia
hospit
children
presum
bacteri
pneumonia
etiolog
agent
caus
pneumonia
vari
age
underli
ill
matur
condit
immun
system
case
acut
pneumonia
extens
invas
test
warrant
epidemiolog
inform
frequent
use
guid
differenti
diagnosi
manag
see
chapter
certain
pathogen
particularli
respiratori
syncyti
viru
rsv
rhinovirus
influenza
virus
mycoplasma
season
instanc
pattern
famili
ill
provid
clue
caus
nonbacteri
agent
purpos
manag
rel
import
etiolog
agent
seri
patient
extens
evalu
extrapol
patient
similar
clinic
syndrom
physic
find
laboratori
result
tabl
list
common
etiolog
agent
acut
pneumonia
children
pneumonia
neonat
manifest
earlyonset
diseas
within
day
life
lateonset
diseas
day
life
earlyonset
infect
caus
organ
acquir
matern
genit
tract
aspir
contamin
amniot
fluid
genit
tract
secret
group
b
streptococcu
frequent
caus
earlyonset
pneumonia
earlyonset
infect
due
group
b
streptococcu
listeria
monocytogen
escherichia
coli
gramneg
bacilli
caus
sever
respiratori
distress
resembl
hyalin
membran
diseas
usual
part
widespread
system
infect
prenat
perinat
risk
factor
includ
preterm
deliveri
matern
chorioamnion
ruptur
membran
hour
increas
risk
neonat
pneumonia
hematogen
dissemin
occur
occasion
infect
mother
pneumonia
due
chlamydia
trachomati
acquir
perinat
becom
symptomat
week
birth
characterist
infant
afebril
bordetella
pertussi
infect
young
infant
sever
complic
apnea
bronchopneumonia
pulmonari
hypertens
wide
avail
extend
panel
rapid
molecular
diagnost
test
virus
increasingli
confirm
import
caus
pneumonia
young
infant
sever
often
fatal
pneumonia
also
result
dissemin
herp
simplex
viru
hsv
infect
noenat
congenit
cytomegaloviru
cmv
treponema
pallidum
less
common
caus
neonat
pneumonia
genit
mycoplasma
ureaplasma
spp
purport
caus
lri
especi
low
birth
weight
infant
recent
studi
determin
etiolog
agent
cap
children
year
age
virus
account
bacteria
mix
infect
case
studi
also
note
viral
pneumonia
common
children
year
age
compar
older
children
wherea
mycoplasma
common
children
year
age
compar
younger
children
virus
overal
virus
account
approxim
cap
childhood
howev
categor
age
virus
account
cap
children
year
compar
year
age
rsv
predomin
viral
pathogen
childhood
pneumonia
account
highest
incid
children
year
age
virus
includ
human
metapneumoviru
hmpv
parainfluenza
virus
type
influenza
virus
b
adenovirus
bocaviru
rhinovirus
enterovirus
rhinovirus
recov
cultur
case
childhood
pneumonia
although
influenza
rsv
hmpv
significantli
associ
cap
children
role
virus
parainfluenza
virus
enterovirus
rhinovirus
coronavirus
bocaviru
difficult
ascrib
owe
dual
viru
detect
ill
detect
well
children
extend
durat
shed
casecontrol
studi
latter
virus
neg
associ
cap
varicellazost
viru
vzv
cmv
hsv
typic
caus
lri
immunocompromis
young
children
case
lri
due
human
parechovirus
hpev
type
report
substanti
role
await
descript
lri
viral
infect
mirror
gener
season
rsv
countri
widespread
immun
hib
conjug
vaccin
frequenc
haemophilu
influenza
type
b
hib
infect
includ
pneumonia
plummet
pneumonia
due
nontyp
b
nontyp
h
influenza
uncommon
otherwis
healthi
children
us
except
prematur
infant
children
underli
chronic
condit
diseas
hospitalassoci
pneumonia
acut
pneumonia
necrot
pneumonia
caus
methicillinsuscept
staphylococcu
aureu
mssa
methicillinresist
aureu
mrsa
communityassoci
mrsa
camrsa
especi
carri
virul
factor
like
pantonvalentin
leukocidin
streptococcu
pyogen
group
streptococcu
frequent
caus
acut
pneumonia
caus
rapidli
progress
sever
pneumonia
frequent
lead
hypoxemia
pleural
effus
within
hour
bacteria
especi
gramneg
organ
rare
caus
pneumonia
previous
healthi
children
caus
lri
prematur
babi
neonat
patient
cystic
fibrosi
sickl
cell
diseas
primari
acquir
immun
defici
immun
suppress
pathogen
varieti
epidemiolog
host
factor
prompt
consider
specif
organ
tabl
import
tuberculosi
alway
suspect
histori
exposur
presenc
hilar
adenopathi
pneumonia
respond
usual
therapi
north
america
europ
primari
tuberculosi
pneumonia
occur
predominantli
children
born
contact
recent
immigr
countri
tuberculosi
endem
contact
infect
adult
hivinfect
children
resid
travel
certain
geograph
area
rais
concern
special
pathogen
coccidioid
immiti
endem
southwestern
us
northern
mexico
part
central
south
america
histoplasma
capsulatum
endem
eastern
central
us
canada
hmpv
influenza
winter
parainfluenza
spring
autumn
rhinovirus
adenovirus
throughout
year
mycoplasma
pneumonia
chlamydophila
pneumonia
lri
due
mycoplasma
pneumonia
affect
schoolag
children
predominantli
molecular
detect
upper
respiratori
secret
younger
children
less
clear
mean
coinfect
either
streptococcu
pneumonia
chlamydophila
pneumonia
occur
infect
due
pneumonia
occur
cycl
unlik
respiratori
virus
transmiss
pneumonia
among
famili
member
slow
median
interv
week
case
pneumonia
rare
ascrib
c
pneumonia
children
us
compar
european
asian
countri
associ
reactiv
airway
diseas
asthma
children
year
age
asymptomat
carriag
c
pneumonia
well
document
confound
assess
pathogen
bacteri
pathogen
bacteri
pneumonia
common
children
live
develop
countri
relat
sever
factor
includ
chronic
malnutrit
crowd
inadequ
vaccin
constant
exposur
biomass
fuel
without
adequ
ventil
variou
test
determin
bacteri
product
blood
respiratori
tract
secret
urin
use
attempt
assign
caus
lri
role
bacteria
posit
case
evid
multipl
sourc
indic
pneumonia
singl
common
caus
bacteri
pneumonia
beyond
first
week
life
caus
bacteri
pneumonia
case
pneumococc
serotyp
caus
uncompl
pneumonia
us
gener
similar
caus
bacteremia
invas
pneumococc
diseas
ipd
acut
otiti
media
see
chapter
era
ipd
includ
pneumonia
occur
increasingli
older
children
underli
medic
condtion
pneumococc
pneumonia
occur
age
group
especi
year
age
pneumonia
occur
host
suscept
virul
pathogen
expos
highdens
aerosol
inoculum
compromis
system
secretori
immun
impair
clearanc
mechan
patient
pneumonia
initi
colon
infect
upper
respiratori
tract
invas
lower
respiratori
tract
usual
occur
normal
defens
mechan
impair
associ
viral
infect
chronic
malnutrit
chronic
aspir
impair
cough
reflex
eg
sedat
neurolog
damag
intub
exposur
environment
pollut
bacteri
pneumonia
occasion
occur
hematogen
rout
earli
stage
lobar
bacteri
pneumonia
proteinrich
edema
fluid
contain
numer
organ
fill
alveoli
lead
mark
capillari
congest
caus
neutrophil
exud
intraalveolar
hemorrhag
decreas
lung
complianc
increas
pulmonari
resist
small
airway
obstruct
air
trap
chang
ventilationperfus
ratio
lead
clinic
sign
respiratori
distress
defens
mechan
lri
consist
anatom
physiolog
barrier
humor
cellmedi
protect
phagocyt
activ
presenc
hair
anterior
nare
trap
particl
size
configur
nasal
turbin
acut
branch
airway
form
protect
anatom
barrier
filtrat
humidif
capac
upper
airway
mucu
product
middl
airway
protect
epiglotti
cough
reflex
elimin
particl
form
physiolog
barrier
mucociliari
blanket
transport
microscop
amount
normal
aspir
oropharyng
flora
particul
matter
tracheobronchi
tree
minim
presenc
bacteria
carina
particl
escap
lower
airway
immunoglobulin
iga
antibodi
secret
upper
airway
igg
igm
leach
local
capillari
lower
airway
alveolar
fluid
surfact
fibronectin
complement
lysozym
ironbind
protein
also
antimicrobi
activ
lower
respiratori
tract
three
distinct
popul
macrophag
alveolar
interstiti
intravascular
macrophag
alveolar
macrophag
preemin
phagocyt
cell
ingest
kill
bacteria
addit
phagocyt
function
interstiti
macrophag
antigenprocess
cell
wherea
intravascular
macrophag
clear
inflammatori
debri
bloodstream
viral
infect
especi
due
influenza
viru
high
oxygen
concentr
uremia
use
alcohol
drug
impair
function
alveolar
macrophag
predispos
pneumonia
cellmedi
immun
play
import
role
pulmonari
infect
caus
virus
intracellular
organ
mycobacterium
tuberculosi
legionella
surviv
within
pulmonari
macrophag
viral
pulmonari
infect
follow
three
patholog
pattern
bronchiol
interstiti
pneumonia
parenchym
infect
first
two
pattern
often
overlap
viral
pneumonia
character
neutrophil
infiltr
lumen
airway
lymphocyt
infiltr
interstitium
parenchyma
lung
giant
cell
format
viral
inclus
within
nucleu
respiratori
cell
histolog
evid
mani
viral
infect
includ
caus
adenoviru
measl
varicella
cmv
epsteinbarr
viru
especi
children
immun
defici
air
trap
disturb
ventilationperfus
ratio
occur
obstruct
obliter
small
airway
thicken
septa
imped
oxygen
diffus
necrosi
bronchial
bronchiolar
epithelium
occur
sever
sometim
fatal
viral
infect
eg
adenoviru
infect
bacteri
pneumonia
follow
five
patholog
pattern
parenchym
infect
inflamm
consolid
lobe
segment
lobe
lobar
pneumonia
classic
pattern
pneumonia
primari
infect
airway
surround
interstitium
bronchopneumonia
often
due
pyogen
aureu
necrot
breathsmin
intercost
retract
young
infant
particularli
born
prematur
fever
absent
apneic
spell
promin
initi
find
c
trachomati
pneumonia
infant
insidi
infant
come
attent
week
staccato
cough
tachypnea
crackl
absenc
fever
wheez
uncommon
eosinophilia
elev
total
serum
igm
concentr
present
infant
children
adolesc
virus
viral
pneumonia
usual
occur
context
preced
upper
respiratori
tract
ill
gradual
increas
irrit
respiratori
congest
cough
posttuss
emesi
fever
patient
may
appear
toxic
although
hypoxia
mark
particularli
young
infant
whose
initi
present
also
apnea
auscultatori
find
anatom
confin
rather
diffus
bilater
wheez
crackl
although
adenoviru
usual
follow
pattern
viral
infect
adenoviru
caus
sever
pneumonia
lobar
consolid
similar
bacteri
infect
especi
sever
immunocompromis
host
bacteri
pneumonia
bacteri
pneumonia
may
follow
sever
day
mild
uri
onset
usual
abrupt
patient
usual
ill
toxic
appear
high
fever
rigor
tachypnea
respiratori
distress
hypoxemia
absent
mild
unless
widespread
diseas
larg
pleural
effus
cough
occur
later
cours
ill
alveolar
debri
swept
upper
airway
unilater
pleurit
chest
pain
abdomin
pain
neck
pain
sepsi
presenc
radiograph
demonstr
infiltr
specif
sign
bacteri
pneumonia
unless
parapneumon
effus
auscultatori
find
usual
limit
anatom
lung
segment
pathogen
major
symptom
lri
due
pneumonia
c
pneumonia
c
burnetii
q
fever
fever
cough
persist
day
onset
pneumonia
caus
pneumonia
usual
well
demarc
malais
headach
photophobia
sore
throat
fever
chill
occur
earli
sometim
subsid
gradual
worsen
nonproduct
cough
ensu
although
coryza
unusu
otiti
media
occur
find
physic
examin
auscult
minim
confin
rale
wheez
presenc
stevensjohnson
syndrom
hemolyt
anemia
patient
pneumonia
suggest
pneumonia
infect
pneumonia
caus
sever
diseas
person
sickl
cell
diseas
acut
chest
syndrom
common
pneumonia
due
c
pneumonia
usual
insidi
onset
sore
throat
hoars
associ
sinus
pneumonia
due
c
burnetii
rare
usual
mild
children
symptomat
patient
intract
headach
myalgia
arthralgia
nonproduct
cough
chest
radiograph
find
includ
segment
lobar
consolid
round
pneumonia
describ
q
fever
pneumonia
highli
probabl
children
fever
cough
tachypnea
short
breath
chest
radiograph
demonstr
pulmonari
infiltr
mani
altern
diagnos
particularli
absenc
fever
chronic
relaps
symptom
sign
includ
foreignbodi
aspir
asthma
gastroesophag
reflux
cystic
fibrosi
congest
cardiac
failur
system
vascul
bronchiol
obliteran
children
develop
chemic
pneumonia
ingest
volatil
hydrocarbon
sever
necrot
pneumonia
high
fever
peripher
neutrophil
count
exceed
chest
radiographi
often
obtain
determin
whether
patient
respiratori
symptom
sign
pneumonia
howev
accur
interpret
chest
radiograph
pneumonia
multipl
challeng
insensit
differenti
bacteri
nonbacteri
caus
fals
neg
children
examin
earli
cours
pneumonia
dehydr
patient
lag
abnorm
find
substanti
inconsist
read
radiologist
influenc
radiologist
knowledg
parenchym
pneumonia
occur
aspir
anaerob
certain
aureu
pneumonia
caseat
granulomat
diseas
due
tuberculosi
peribronchi
interstiti
diseas
secondari
parenchym
infiltr
occur
viral
pneumonia
complic
bacteri
infect
bacteri
pneumonia
airspac
becom
fill
transud
neutrophil
exud
impair
oxygen
diffus
proxim
infect
alveoli
rich
pulmonari
vascular
bed
increas
risk
bacteremia
septicemia
shock
symptom
pneumonia
vari
nonspecif
may
subtl
depend
sever
factor
includ
etiolog
agent
age
host
inoculum
size
individu
immun
respons
see
chapter
acut
onset
fever
rapid
breath
tachypnea
cough
classic
fever
absent
young
infant
c
trachomati
b
pertussi
ureaplasma
infect
infant
manifest
poor
feed
increas
fussi
children
year
age
often
prodrom
lowgrad
fever
rhinorrhea
due
viral
uri
develop
lower
respiratori
tract
symptom
fever
rapid
breath
preced
onset
cough
children
older
children
complain
pleurit
chest
pain
nuchal
rigid
refer
lobe
involv
sign
respiratori
distress
includ
tachypnea
hypoxemia
oxygen
satur
apnea
increas
work
breath
subcost
intercost
suprastern
retract
nasal
flare
grunt
alter
mental
statu
guidelin
develop
world
health
organ
clinic
diagnosi
pneumonia
develop
countri
highlight
tachypnea
retract
two
best
indic
lri
tachypnea
defin
breathsmin
infant
month
year
children
year
age
among
children
year
age
tachypnea
defin
highest
sensit
specif
radiolog
confirm
pneumonia
less
sensit
specif
earli
diseas
tachypnea
occur
condit
fever
asthma
cardiac
diseas
metabol
acidosi
predict
valu
clinic
find
pneumonia
studi
repeatedli
one
studi
combin
respiratori
rate
breathsmin
oxygen
satur
presenc
nasal
flare
children
month
age
highli
associ
radiograph
confirm
pneumonia
oxygen
satur
frequent
decreas
moder
sever
pneumonia
indic
hospit
admiss
hypoxem
infant
child
may
appear
cyanot
although
hypoxemia
use
accessori
muscl
respir
head
bob
nasal
flare
grunt
predict
pneumonia
absenc
exclud
pneumonia
decreas
bronchial
breath
sound
egophoni
e
chang
bronchophoni
tactil
fremitu
dull
percuss
specif
sign
lung
consolid
crackl
absent
dehydr
patient
isol
wheez
prolong
expir
associ
bronchiol
uncommon
bacteri
pneumonia
almost
three
fourth
children
radiograph
confirm
pneumonia
appear
ill
sever
ill
correl
likelihood
bacteri
caus
approxim
children
year
age
bodi
temperatur
white
blood
cell
wbc
count
without
altern
sourc
major
infect
symptom
sign
lower
respiratori
tract
diseas
radiograph
confirm
pneumonia
one
studi
determin
interobserv
agreement
sign
pneumonia
observ
agreement
clinic
sign
respiratori
rate
cyanosi
compar
auscultatori
sign
crackl
retract
wheez
pneumonia
unfortun
neither
respiratori
rate
cyanosi
sensit
specif
indic
hypoxia
oxygen
satur
measur
child
respiratori
distress
neonat
bacteri
infect
due
group
b
streptococcu
l
monocytogen
gramneg
bacilli
usual
manifest
respiratori
distress
first
hour
life
septicemia
infect
site
domin
clinic
present
pneumonia
children
month
age
usual
character
tachypnea
respiratori
rate
part
ii
clinic
syndrom
cardin
featur
infecti
diseas
approach
diagnosi
initi
manag
circular
appear
lung
infiltr
common
children
year
age
bacteri
pneumonia
often
due
pneumonia
although
rare
case
h
influenza
aureu
atyp
organ
c
burnetii
respons
enlarg
calcifi
hilar
lymph
node
suggest
tuberculosi
fungal
infect
histoplasma
coccidioid
mycoplasma
chronic
infect
cystic
fibrosi
caus
hilar
lymphadenopathi
pneumatocel
thinwal
airor
fluidfil
caviti
result
alveolar
ruptur
usual
associ
infect
due
aureu
necrot
compon
pneumonia
pyogen
h
influenza
gramneg
bacteria
anaerob
infect
see
chapter
consider
radiograph
improv
pneumonia
lag
clinic
improv
complet
resolut
radiolog
abnorm
children
may
take
week
followup
radiographi
indic
persist
atelectasi
complic
pneumonia
recurr
pneumonia
round
pneumonia
exclud
tumor
caus
prospect
studi
examin
util
routin
acutephas
reactant
children
wbc
count
differenti
creactiv
protein
erythrocyt
sediment
rate
pneumonia
conclud
test
differenti
bacteri
viral
pneumonia
accur
cochran
metaanalysi
found
patient
bacteri
pneumonia
usual
creactiv
protein
level
mgdl
detect
caus
agent
pneumonia
import
optim
manag
challeng
without
use
invas
techniqu
mild
moder
ill
ambulatori
patient
usual
manag
empir
without
specif
diagnost
test
identifi
specif
etiolog
agent
import
patient
admit
hospit
underli
condit
commun
outbreak
caus
appar
emerg
agent
number
investig
may
necessari
confirm
etiolog
diagnosi
viral
pathogen
best
identifi
recov
detect
organ
tissu
cultur
detect
viral
antigen
nucleic
acid
respiratori
tract
secret
use
immunofluoresc
polymeras
chain
reaction
pcr
techniqu
although
viral
cultur
still
consid
gold
standard
confirm
diagnosi
clinic
util
low
difficulti
durat
vitro
growth
realtim
pcr
test
panel
rapidli
detect
common
viral
atyp
bacteri
agent
cap
ad
advantag
includ
facilit
appropri
treatment
decis
cohort
contagi
patient
nasopharyng
wash
aspir
sensit
specimen
contain
infect
epitheli
cell
clinic
interpret
pcr
detect
essenti
detect
may
relat
prolong
shed
presenc
viral
agent
upper
respiratori
tract
exclud
presenc
secondari
bacteri
pneumonia
obtain
acut
convalesc
sera
assess
rise
specif
antibodi
usual
confin
research
set
specif
diagnosi
bacteri
pneumonia
problemat
infant
children
effect
cough
sputum
older
children
sputum
sampl
consid
appropri
microbiolog
evalu
gram
stain
reveal
squamou
epitheli
cell
neutrophil
per
lowpow
field
predomin
organ
cultur
nasopharyng
specimen
reliabl
tracheal
aspir
use
cultur
perform
direct
laryngoscopi
cultur
sampl
obtain
cathet
directli
pass
tracheostomi
endotrach
nasotrach
tube
limit
frequent
contamin
upper
respiratori
tract
organ
howev
could
evalu
sputum
sampl
quantit
cultur
perform
bronchoalveolar
lavag
bal
specimen
use
isol
coloni
count
ml
bal
recommend
sever
ill
intub
immunocompromis
individu
respond
initi
antibiot
therapi
preval
bacteremia
pneumonia
report
depend
whether
ill
mild
clinic
inform
accuraci
interpret
prescript
antibiot
link
radiographi
routin
chest
radiographi
appear
alter
clinic
outcom
acut
lri
radiographi
restrict
special
circumst
chest
radiographi
indic
confirm
presenc
determin
locat
pneumonia
children
hospit
sever
ill
recurr
diseas
chronic
medic
condit
poor
respons
initi
antibiot
therapi
complic
pneumonia
diagnosi
uncertain
altern
caus
respiratori
distress
must
exclud
bilater
diffus
infiltr
seen
pneumonia
caus
virus
p
jirovecii
l
pneumophila
occasion
pneumonia
c
pneumonia
pneumonia
fig
caus
focal
radiograph
abnorm
proport
clinic
find
distinctli
confin
lobar
segment
abnorm
larg
pleural
effus
suggest
bacteri
infect
fig
rare
pneumonia
adenoviru
manifest
find
round
pneumonia
peak
stage
ill
young
infant
month
age
suspect
pertussi
viral
bronchiol
risk
apnea
hypoxia
pertussi
pulmonari
hypertens
infant
month
age
hospit
uncertain
followup
fail
initi
oral
antibiot
therapi
pneumonia
necrot
associ
parapneumon
effus
empyema
lung
abscess
children
month
age
mild
moder
sever
pneumonia
manag
effect
without
hospit
provid
reliabl
followup
absenc
complic
diagnost
test
determin
etiolog
pneumonia
radiographi
seldom
requir
use
infant
children
manag
outpati
influenza
season
suspect
influenza
treat
oseltamivir
antibiot
therapi
prescrib
find
suggest
bacteri
infect
treatment
empir
base
like
etiolog
agent
age
consid
underli
medic
condit
like
antimicrobi
suscept
toler
cost
azithromycin
appropri
treatment
infant
infect
pertussi
c
trachomati
ureaplasma
vigil
drugassoci
infantil
hypertroph
pylor
stenosi
prudent
especi
infant
week
age
azithromycin
dose
pertussi
mgkg
per
day
daili
day
highdos
amoxicillin
therapi
mgkgday
prefer
outpati
therapi
cap
infant
children
pharmacokinet
simul
studi
predict
excess
failur
treatment
pneumonia
due
pneumonia
minim
inhibitori
concentr
mic
use
highdos
amoxicillin
divid
dose
dose
divid
dose
prefer
area
pneumonia
mic
occur
antibioticexperienc
children
highdos
amoxicillinclavulan
formul
ceftriaxon
given
intraven
activ
agent
like
gramposit
gramneg
respiratori
pathogen
wherea
trimethoprimsulfamethoxazol
azithromycin
cefaclor
cefprozil
least
activ
cefuroxim
axetil
could
use
patient
pneumonia
nontyp
hypersensit
reaction
penicillin
clindamycin
could
use
patient
type
hypersensit
reaction
penicillin
suspect
staphylococc
pneumonia
aspir
pneumonia
one
studi
central
us
howev
pneumonia
case
resist
clindamycin
empir
use
cefdinir
azithromycin
option
mild
pneumonia
patient
allerg
unrespons
initi
therapi
amoxicillin
drug
limit
activ
pneumonia
nontyp
h
influenza
children
year
age
mycoplasma
c
pneumonia
suspect
empir
treatment
macrolid
doxycyclin
may
appropri
singl
therapi
combin
amoxicillin
pyogen
bacteria
also
suspect
highdos
amoxicillinclavulan
clindamycin
effect
children
aspir
pneumonia
fluoroquinolon
therapi
treatment
use
agent
enhanc
gramposit
activ
eg
levofloxacin
moxifloxacin
consid
adolesc
frequent
aspir
well
infect
atyp
organ
activ
includ
pneumonia
c
pneumonia
durat
antibiot
therapi
pneumonia
also
empir
depend
sever
factor
includ
patient
age
sever
ill
underli
ill
respons
therapi
case
durat
therapi
day
oseltamivir
therapi
influenza
initi
soon
possibl
ie
test
result
children
high
risk
complic
eg
underli
medic
condit
includ
asthma
children
hospit
influenza
oral
oseltamivir
phosphat
approv
us
food
drug
administr
children
week
age
inhal
zanamavir
also
approv
altern
antiinfluenza
therapi
children
year
age
influenza
underli
pulmonari
diseas
hypoxemia
oxygen
satur
singl
import
indic
hospit
hypoxem
child
greater
risk
death
adequ
oxygen
child
indic
includ
cyanosi
rapid
respiratori
rate
breathsmin
infant
breathsmin
child
apnea
dyspnea
expiratori
grunt
dehydr
toxic
appear
poor
oral
intak
recurr
pneumonia
underli
medic
condit
uncertain
observ
home
requir
hospit
increas
case
complic
pneumonia
parapneumon
effus
empyema
pneumonia
frequent
caus
bacterem
pneumonia
without
empyema
blood
cultur
confirm
etiolog
diagnosi
provid
suscept
test
result
alter
antibiot
manag
blood
cultur
recommend
children
hospit
especi
parapneumon
effus
empyema
urin
antigen
test
detect
pneumococc
infect
children
us
longer
recommend
low
specif
diseas
low
sensit
legionella
urin
antigen
test
high
sensit
specif
perform
select
research
ongo
develop
test
identifi
pneumonia
character
etiolog
eg
urin
metabol
exhal
breath
condens
test
could
aid
clinic
diagnosi
futur
pathogen
pneumonia
detect
expand
respiratori
panel
pcr
test
use
broadli
mycoplasma
cultur
also
avail
commerci
hospit
laboratori
take
week
complet
cold
agglutinin
mycoplasmaspecif
igm
antibodi
agglutin
human
red
cell
found
individu
pneumonia
pneumonia
acut
phase
diseas
low
titer
cold
agglutinin
occur
respiratori
viral
infect
collagen
vascular
diseas
malign
tropic
diseas
make
less
specif
diagnost
test
well
complement
fixat
cf
continu
wide
use
serodiagnosi
test
mycoplasma
pneumonia
sensit
specif
posit
titer
defin
fourfold
higher
increas
titer
pair
sera
singl
titer
cf
test
neg
young
children
mild
diseas
fals
posit
certain
inflammatori
autoimmun
condit
includ
neurolog
diseas
bacteri
mening
acut
pancreat
crossreact
host
autoantibodi
cf
antigen
commerci
avail
enzym
immunoassay
antim
pneumonia
igm
iga
unaccept
high
falseposit
rate
comparison
realtim
pcr
test
microimmunofluoresc
serolog
show
superior
pcr
earli
detect
c
pneumonia
infect
interpret
detect
requir
asymptomat
infect
occur
specif
serolog
effect
detect
infect
agent
caus
atyp
pneumonia
name
c
psittaci
c
burnetii
screen
test
tuberculosi
includ
place
skin
test
obtain
whole
blood
specimen
interferon
releas
assay
igra
patient
immedi
famili
member
signific
contact
also
test
children
primari
infect
acut
ill
patient
igra
skin
test
nonreact
gener
specif
anergi
addit
data
util
igra
diagnosi
tuberculosi
children
year
age
suspicion
tuberculosi
multipl
specimen
obtain
smear
cultur
includ
daili
sampl
sputum
spontan
induc
gastric
aspir
without
bal
specimen
pcr
test
specimen
tuberculosi
compar
microscopi
cultur
higher
sensit
children
clinic
diseas
see
also
pathogenspecif
chapter
text
neonat
pneumonia
best
manag
least
initi
hospit
risk
rapid
decompens
empir
antimicrobi
therapi
similar
treatment
neonat
sepsi
see
chapter
therapi
modifi
base
cultur
result
clinic
respons
sever
present
infant
month
age
mild
pneumonia
manag
outpati
close
medic
supervis
provid
appear
ill
respiratori
distress
hypoxemia
oxygen
satur
feed
intoler
sign
dehydr
underli
chronic
medic
condit
prefer
hospit
sever
epidemiolog
studi
question
linkag
asthma
respiratori
morbid
occur
later
childhood
viral
bronchiol
atyp
pneumonia
infanc
bacteri
pneumonia
rsv
c
trachomati
particular
implic
one
studi
link
asthma
c
pneumonia
infect
abnorm
pulmonari
function
adult
report
pneumonia
pertussi
earli
childhood
longitudin
studi
pulmonari
function
children
bronchiol
howev
suggest
abnorm
may
preced
acut
infecti
ill
thu
remain
unclear
whether
childhood
pneumonia
caus
chronic
pulmonari
diseas
respiratori
viral
infect
transmit
direct
inocul
hand
contamin
respiratori
secret
conjunctiv
nasal
mucosa
spread
airborn
droplet
also
occur
occasion
adequ
hand
hygien
caregiv
medic
personnel
singl
import
method
prevent
hospitalassoci
infect
hospit
patient
respiratori
tract
infect
year
age
older
children
unabl
follow
proper
respiratori
etiquett
care
isol
precaut
droplet
contact
prevent
transmiss
larg
droplet
spread
infect
small
droplet
pertussi
reduc
use
airborn
precaut
negativepressur
room
univers
immun
pneumococc
conjug
vaccin
reduc
dramat
incid
invas
pneumococc
diseas
pneumonia
children
well
young
adult
elderli
peopl
commun
herd
protect
children
year
age
adolesc
heighten
risk
invas
pneumococc
diseas
receiv
follow
pneumococc
polysaccharid
vaccin
rsv
bronchiol
pneumonia
reduc
highrisk
infant
avoid
multipl
environment
risk
factor
see
chapter
monthli
administr
rsv
monoclon
antibodi
reduc
hospit
due
rsv
recommend
certain
highrisk
infect
annual
vaccin
influenza
recommend
individu
month
age
emphasi
strict
implement
underli
medic
condit
chronic
lung
diseas
includ
mild
asthma
neuromuscular
disord
congenit
cardiac
condit
diabet
high
risk
sever
complic
lower
respiratori
tract
influenza
infect
anticip
prevent
influenza
varicella
immun
reduc
incid
bacteri
pneumonia
children
due
pneumonia
aureu
pyogen
acut
complic
bacteri
pneumonia
includ
parapneumon
effus
empyema
necrot
pneumonia
pneumatocel
format
lung
abscess
late
signific
increas
rel
incid
complic
bacteri
pneumonia
infant
children
live
north
america
exact
reason
still
obscur
pleural
effus
presenc
abnorm
fluid
collect
viscer
pariet
pleura
pleural
effus
classifi
transud
exud
base
light
criteria
biochem
characterist
fluid
rel
concentr
pleural
fluid
protein
serum
protein
transud
versu
exud
tabl
transud
infrequ
caus
infect
wherea
exud
infecti
noninfecti
caus
noninfecti
caus
pleural
effus
list
tabl
sever
drug
includ
hydralazin
nitrofurantoin
dantrolen
amiodaron
methysergid
procarbazin
bromocriptin
methotrex
agent
associ
lupuslik
reaction
associ
pleural
effus
parapneumon
effus
inflammatori
fluid
collect
adjac
pneumon
process
seen
overal
children
oxygen
assess
continu
measur
oxygen
satur
arteri
po
hypox
infant
children
may
appear
cyanot
termin
mental
agit
clinic
evid
increas
irrit
indic
hypoxemia
supplement
oxygen
therapi
indic
patient
whose
oxygen
satur
persist
sole
relianc
puls
oximetri
valu
without
blood
ga
determin
hazard
ill
patient
hypercarbia
import
sign
impend
respiratori
failur
rapid
breath
fever
decreas
oral
intak
fatigu
increas
fluid
requir
patient
hydrat
oral
given
small
volum
fluid
frequent
intraven
fluid
usual
necessari
serious
ill
children
rapid
breath
increas
likelihood
pulmonari
aspir
syndrom
inappropri
secret
antidiuret
hormon
siadh
occur
one
third
patient
hospit
pneumonia
associ
sever
diseas
poor
outcom
fluid
restrict
requir
case
improv
outcom
malnutrit
associ
wors
prognosi
pneumonia
infant
small
children
fare
better
fed
small
quantiti
frequent
prevent
aspir
placement
enter
feed
tube
parenter
nutrit
may
necessari
serious
ill
intub
child
maintain
nutrit
balanc
persist
high
fever
increas
basal
metabol
rate
oxygen
consumpt
similarli
pain
interfer
depth
breath
abil
cough
effect
ageappropri
antipyret
analges
agent
may
necessari
oral
antibiot
effect
certain
hospit
older
infant
children
uncompl
pneumonia
good
oral
intak
otherwis
initi
intraven
therapi
ampicillin
appropri
ampicillinsulbactam
thirdgener
cephalosporin
consid
previous
receiv
antibiot
sever
pneumonia
thirdgener
cephalosporin
consid
area
pneumonia
mic
preval
intraven
clindamycin
may
consid
patient
hypersensit
penicillin
suspect
staphylococc
infect
aspir
pneumonia
intraven
cefepem
ceftazidim
piperacillintazobactam
use
empir
therapi
immunocompromis
patient
pneumonia
especi
neutropenia
empir
antifung
therapi
consid
initi
inadequ
respons
antibiot
therapi
vancomycin
linezolid
usual
given
mrsaconfirm
infect
empir
children
sever
lifethreaten
pneumonia
patient
cystic
fibrosi
need
adequ
antibiot
coverag
aureu
pseudomona
spp
sputum
cultur
guid
choic
broad
antibiot
therapi
reconsid
pend
identif
organ
suscept
test
result
pend
clinic
cours
gener
appropri
oral
antibiot
select
complet
therapi
uncompl
pneumonia
patient
respond
therapi
begin
toler
oral
fluid
viral
pneumonia
complic
bacteri
superinfect
variabl
frequenc
evid
suggest
withhold
antibiot
hospit
children
pneumonia
clinic
compat
prove
viral
origin
safe
prefer
broad
use
empir
antibiot
treatment
use
specif
antivir
therapi
influenza
depend
pathogen
sever
clinic
cours
benefitversusrisk
consider
use
aerosol
ribavirin
treatment
rsv
acut
lri
guid
recommend
american
academi
pediatr
although
valu
treatment
question
mortal
due
cap
uncommon
beyond
infanc
europ
north
america
improv
enhanc
immun
rate
earli
access
medic
care
avail
appropri
antimicrobi
therapi
healthi
children
acut
lri
recov
without
complic
sequela
patient
especi
prematur
infant
immunocompromis
host
children
chronic
lung
neuromuscular
sickl
cell
diseas
cardiovascular
diseas
acut
complic
common
pneumonia
hospit
children
parapneumon
effus
classifi
uncompl
complic
base
fluid
ph
glucos
lactat
dehydrogenas
ldh
concentr
see
tabl
empyema
refer
purul
collect
exud
pleural
sac
repres
spectrum
uncompl
complic
parapneumon
effus
parapneumon
effus
usual
occur
complic
pyogen
bacteri
pneumonia
occur
occasion
secondari
etiolog
agent
eg
mycoplasma
adenoviru
consequ
infect
anoth
contigu
site
estim
incid
empyema
hospit
children
us
report
approxim
per
rang
increas
occur
incid
bacteri
pneumonia
especi
due
pneumonia
decreas
increas
empyema
thought
relat
increas
pneumonia
serotyp
pyogen
camrsa
case
complic
pneumonia
requir
surgic
drainag
occur
children
year
age
necrot
pneumonia
pneumatocel
frequent
coexist
empyema
predominantli
children
year
age
risk
develop
empyema
also
increas
children
certain
underli
infecti
influenza
medic
condit
includ
congenit
heart
diseas
chronic
pulmonari
condit
immun
defici
neuromuscular
disord
complic
effus
empyema
seriou
ill
often
associ
signific
morbid
need
care
intens
care
unit
surgic
drainag
longer
hospit
stay
longer
antibiot
cours
result
high
healthcar
cost
mortal
rate
howev
low
except
children
year
age
etiolog
agent
pneumonia
common
caus
cultureconfirm
cultureneg
parapneumon
effus
although
penicillinnonsuscept
pneumonia
strain
recogn
late
earli
serotyp
highli
invas
penicillinsuscept
pneumococc
strain
develop
late
utah
pneumonia
serotyp
emerg
virul
agent
complic
pneumonia
introduct
serotyp
detect
area
us
half
case
empyema
children
mani
case
pneumonia
detect
pcr
fluid
blood
cultur
adult
respiratori
distress
syndrom
especi
patient
pretreat
antibiot
recent
studi
greec
one
third
children
pneumonia
serotyp
pneumonia
pleural
effus
immun
month
age
recommend
dose
case
occur
children
whose
immun
began
infanc
includ
recommend
dose
univers
childhood
immun
hib
made
hib
rare
caus
parapneumon
effus
camrsa
import
caus
complic
pneumonia
southeast
asia
aureu
common
caus
less
frequent
group
streptococcu
pseudomona
aeruginosa
mix
anaerob
pathogen
mycobacterium
spp
rare
fungi
parasit
etiolog
agent
although
effus
accompani
pneumonia
due
pneumonia
common
virus
seldom
larg
enough
requir
intervent
parapneumon
fluid
aureu
infect
frequent
steril
especi
patient
receiv
antibiot
infect
caus
fastidi
organ
situat
pcr
test
often
confirm
etiolog
normal
circumst
pleural
space
contain
small
amount
ml
kg
low
protein
fluid
form
lubric
film
two
layer
pleura
pleural
circul
maintain
delic
balanc
secret
absorpt
pleural
fluid
lymphat
vessel
balanc
disturb
fluid
accumul
transud
occur
chang
hydrostat
forc
normal
capillari
permeabl
wherea
exud
result
increas
capillari
permeabl
lymphat
obstruct
pleural
mesotheli
macrophag
contribut
innat
local
defens
infect
pathogen
gain
entri
pleural
space
direct
extens
alveoli
hematogen
spread
skin
surfac
penetr
injuri
ruptur
esophagu
intraabdomin
site
diaphragm
direct
extens
alveoli
far
common
certain
pathogen
aureu
pneumonia
pyogen
demonstr
tropism
pleural
surfac
reason
well
understood
like
includ
virul
factor
exotoxin
endotoxin
attach
molecul
exposur
pleural
mesotheli
cell
lipopolysaccharid
thrombin
bacteria
incit
innat
adapt
inflammatori
respons
caus
pleural
mesotheli
macrophag
dysfunct
vascular
endotheli
growth
factor
releas
potenti
endotheli
injuri
increas
capillari
permeabl
extravas
pulmonari
interstiti
fluid
pleural
space
mesotheli
cell
recruit
neutrophil
monocyt
secret
larg
amount
chemokin
includ
pleural
fluid
inhibit
bacteri
protein
result
acid
purul
fluid
ie
empyema
acid
environ
pleural
fluid
suppress
bacteri
growth
interfer
antibiot
activ
diseas
progress
inflammatori
cytokin
releas
activ
coagul
lead
deposit
fibrin
three
stage
natur
cours
empyema
recogn
first
exud
phase
fluid
low
cellular
content
normal
glucos
normal
ph
second
fibrinopurul
phase
frank
pu
contain
neutrophil
fibrin
form
glucos
ph
fluid
low
fibrin
pu
coat
inner
surfac
pleura
interf
lung
expans
lead
locul
third
organiz
phase
late
stage
fibroblast
migrat
exud
viscer
part
ii
clinic
syndrom
cardin
featur
infecti
diseas
approach
diagnosi
initi
manag
chest
tube
placement
superior
comput
tomographi
ct
detect
earli
locul
septat
qualiti
ultrasonographi
depend
level
experi
oper
although
ct
necessari
routin
differenti
simpl
parapneumon
effus
empyema
ct
may
indic
evalu
parenchym
diseas
necrot
pneumonia
lung
abscess
determin
noninfecti
caus
aid
surgeon
thoracotomi
thoracoscopi
children
parapneumon
effus
empyema
often
elev
peripher
wbc
count
left
shift
neutrophil
elev
creactiv
protein
thrombocytosi
plateletsmm
hypoalbuminemia
occur
effus
larg
proteinac
hyponatremia
rais
consider
siadh
blood
cultur
obtain
therapi
posit
result
use
manag
pleural
fluid
steril
cultur
sputum
tracheal
aspir
possibl
may
use
gram
stain
determin
whether
qualiti
sampl
good
neutrophilslowpow
field
absent
squamou
epitheli
cell
singl
organ
type
predomin
pleural
fluid
specimen
inspect
determin
color
odor
putrid
odor
pathognomon
anaerob
infect
charact
bloodi
purul
seropurul
serosanguin
centrifug
cloudi
persist
cloudi
suggest
chylothorax
analyz
total
wbc
count
differenti
special
stain
cultur
cellular
histolog
flow
cytometri
perform
infecti
etiolog
uncertain
empyema
like
biochem
analysi
reveal
pleural
fluidtoserum
ratio
ldh
ph
glucos
mgdl
ldh
ul
biochem
analysi
rare
influenc
manag
pediatr
infecti
diseas
societi
infecti
diseas
societi
america
guidelin
recommend
evalu
unless
patient
underli
condit
eg
collagen
vascular
diseas
cytokin
level
pleural
fluid
especi
expect
high
empyema
level
may
use
differenti
complex
simpl
parapneumon
effus
total
differenti
wbc
count
pleural
fluid
help
differenti
bacteria
mycobacteria
fungi
infect
malign
presenc
neutrophilsmm
usual
empyema
lymphocyt
predomin
suggest
tuberculosi
fungal
mycoplasma
infect
also
indic
chylothorax
mix
mononuclear
cell
type
suggest
chronic
process
tuberculosi
malign
uremia
collagen
vascular
diseas
eosinophil
effus
adult
especi
air
blood
pleural
space
suggest
tuberculosi
asbestosi
malign
paragonimiasi
drugrel
hypersensit
pleurisi
collagen
vascular
diseas
parasit
infect
idiopath
case
bacteriolog
examin
alway
includ
gram
stain
cultur
aerob
anaerob
bacteria
acidfast
stain
cultur
tuberculosi
well
fungal
stain
cultur
obtain
fluid
sputum
clinic
indic
rapid
nonculturebas
diagnost
test
pcr
immunoassay
rapid
antigen
test
increasingli
perform
rate
cultur
posit
low
knowledg
etiolog
aid
manag
tubercul
pleural
effus
usual
caus
delay
hypersensit
reaction
mycobacteri
antigen
pleural
space
diagnosi
often
delay
pauciti
organ
pleural
fluid
anergi
tuberculin
skin
test
igra
blood
high
level
adenosin
deaminas
iul
interferon
pgml
pleural
fluid
suggest
tubercul
effus
rapid
accur
diagnosi
well
predict
rifampin
resist
possibl
use
xpert
mtbrif
cepheid
sunnyval
ca
assay
pleural
biopsi
pleural
fluid
specimen
patient
suspect
tubercul
pleural
effus
neg
sputum
smear
acidfast
bacilli
pleural
biopsi
consid
diagnos
granulomat
infect
histoplasmosi
fungal
infect
francisella
tularensi
malign
main
object
therapi
erad
infect
reestablish
pleural
fluid
circul
therebi
reinstat
normal
lung
pariet
pleura
produc
nonelast
membran
call
pleural
peel
avail
antibiot
spontan
drainag
chest
wall
empyema
necessitan
bronchu
bronchopleur
fistula
sometim
follow
event
rare
usual
due
healthcareassoci
antibioticresist
bacteria
insidi
progress
actinomycosi
clinic
radiograph
manifest
effus
suspect
respons
lobar
lobular
alveolar
pneumonia
appropri
antibiot
therapi
slow
clinic
deterior
treatment
symptom
pleural
effus
begin
nonspecif
malais
lethargi
fever
follow
cough
rapid
breath
latter
expect
children
complex
parapneumon
effus
dyspnea
difficulti
breath
grunt
becom
appar
effus
progress
pain
chest
abdomen
develop
involv
side
associ
high
fever
chill
rigor
child
may
splint
lie
involv
side
minim
pain
patient
usual
ill
toxic
appear
febril
signific
tachypnea
shallow
respir
sever
respiratori
distress
hypotens
septic
shock
scoliosi
may
note
involv
side
affect
side
may
tender
palpat
auscult
involv
side
breath
sound
usual
frankli
diminish
crackl
associ
pneumonia
may
audibl
pleural
rub
may
audibl
effus
small
percuss
note
dull
effus
free
flow
contrast
dull
decreas
effus
organ
plain
chest
radiographi
sensit
physic
examin
less
sensit
ultrasonagraphi
detect
small
effus
chest
radiograph
indic
size
locul
effus
whether
drainag
like
indic
defin
parenchym
lung
consolid
well
unexpect
underli
caus
effus
mass
hilar
adenopathi
cardiomegali
blunt
costophren
angl
thicken
normal
paperthin
pleuralshadow
subpulmon
densiti
suggest
pleural
effus
fig
compress
lung
shift
trachea
away
effus
may
seen
effus
larg
usual
ml
later
decubitu
film
differenti
free
effus
locul
collect
pulmonari
consolid
pleural
thicken
chest
radiograph
howev
differenti
parapneumon
effus
empyema
ultrasonographi
imag
modal
choic
portabl
inexpens
involv
radiat
exposur
differenti
parenchym
pleural
space
diseas
help
local
estim
size
effus
precis
identifi
best
site
thoracentesi
fail
medic
therapi
recommend
base
sever
studi
show
compar
outcom
complic
procedur
safeti
cost
favor
chemic
debrid
fibrinolysi
howev
metaanalysi
show
primari
oper
therapi
compar
nonop
therapi
associ
lower
cumul
inhospit
mortal
rate
vs
rate
reintervent
vs
addit
primari
oper
therapi
associ
shorter
durat
hospit
vs
day
chest
tube
day
vs
day
antibiot
therapi
vs
day
respect
expert
agre
either
approach
reason
choic
procedur
depend
local
expertis
cost
consider
patient
prefer
avail
fibrinolyt
agent
includ
urokinas
streptokinas
alteplas
alteplas
commonli
use
fibrinolyt
agent
us
urokinas
avail
streptokinas
limit
efficaci
possibl
allerg
reaction
common
advers
effect
fibrinolyt
therapi
includ
fever
discomfort
intrapleur
bleed
anaphylaxi
fibrinolysi
contraind
patient
bronchopleur
fistula
air
leak
could
caus
tension
pneumothorax
vat
surgeri
fibrin
materi
debrid
locul
broken
drainag
purul
materi
pleural
space
establish
vat
effect
perform
earli
cours
complex
effus
empyema
good
outcom
rel
safe
compar
open
thoracotomi
vat
less
invas
compar
success
rate
earlier
resolut
diseas
shorter
hospit
stay
better
cosmet
appeal
partial
decort
frequent
accomplish
necessari
contraind
perform
vat
includ
inabl
access
pleural
caviti
thick
purul
fluid
sever
fibrosi
bronchoscopi
may
indic
anaerob
infect
hasten
drainag
remov
foreign
bodi
open
pleural
decort
reserv
patient
come
optim
manag
late
entrap
lung
persist
sever
restrict
lung
diseas
children
improv
surgic
drainag
evidenc
improv
activ
appetit
vital
sign
chest
physic
find
resolv
acut
phase
reactant
radiograph
examin
relat
chest
tube
remov
followup
chest
radiograph
usual
necessari
unless
child
persist
symptom
previou
episod
followup
chest
radiograph
latter
indic
delay
week
radiograph
resolut
lag
clinic
resolut
children
complex
parapneumon
effus
empyema
recov
complet
despit
sever
initi
present
mortal
rate
previous
healthi
children
medic
manag
antibiot
chest
tube
drainag
death
report
children
underw
fibrinolyt
procedur
vat
open
thoracotomi
histor
mortal
highest
small
infant
increas
morbid
expect
children
underli
medic
condit
eg
malnutrit
neuromuscular
disord
chronic
pulmonari
diseas
infect
due
mrsa
multidrugresist
organ
longterm
prospect
followup
studi
children
treat
complex
effus
empyema
show
sequela
despit
substanti
complic
within
month
ill
recent
studi
evalu
longterm
effect
parapneumon
effus
especi
children
prior
histori
asthma
conclud
longterm
import
effect
despit
small
chang
lung
function
exercis
capac
necrot
pneumonia
lung
abscess
repres
spectrum
diseas
etiolog
cours
children
differ
compar
adult
lung
abscess
usual
occur
consequ
local
lung
infect
particularli
virul
pyogen
bacteria
necrot
pneumonia
otherwis
healthi
child
usual
resolv
antimicrobi
treatment
occasion
progress
format
pneumatocel
bleb
lung
parenchyma
creat
coalesc
alveolar
space
ruptur
function
achiev
either
medic
surgic
intervent
depend
age
patient
size
effus
sever
respiratori
distress
locul
failur
initi
medic
therapi
support
care
use
appropri
antipyret
analges
oxygen
supplement
fluid
therapi
must
institut
earli
patient
must
monitor
close
recogn
respiratori
deterior
central
respiratori
depress
excess
analges
fluid
overload
relat
siadh
chest
physiotherapi
avoid
caus
discomfort
compromis
respiratori
effort
antimicrobi
therapi
choos
therapi
consider
given
probabl
pathogen
predict
age
pathogen
geograph
resist
pattern
clinic
circumst
commun
healthcar
onset
host
factor
immunocompet
compromis
radiograph
find
gram
stain
cultur
pleural
fluid
children
small
uncompl
effus
manag
outpati
empir
antibiot
regimen
cap
hospit
patient
ceftriaxon
cefotaxim
given
intraven
recommend
empir
therapi
adequ
treat
pneumonia
pyogen
vancomycin
ad
patient
ill
appear
camrsa
hospitalacquir
mrsa
consid
potenti
pathogen
area
camrsa
highli
clindamycin
suscept
clindamycin
could
adequ
addit
vancomycin
poor
pharmacokinet
infect
lung
agent
good
mrsa
activ
includ
linezolid
telavancin
ceftarolin
quinupristindalfopristin
agent
consid
secondlin
treatment
patient
respond
vancomycin
therapi
daptomycin
use
inactiv
surfact
patient
suspect
pneumonia
aspir
clindamycin
use
instead
vancomycin
cover
anaerob
bacteria
case
atyp
pathogen
suspect
macrolid
children
year
doxycyclin
children
year
may
ad
specif
pathogen
detect
clinic
cours
microbiolog
screen
cultur
make
staphylococc
infect
highli
unlik
antibiot
spectrum
narrow
durat
parenter
therapi
total
treatment
individu
basi
clinic
respons
adequaci
drainag
common
practic
replac
parenter
therapi
oral
therapi
substanti
improv
occur
patient
good
oral
intak
continu
antibiot
total
cours
week
empyema
treatment
may
prolong
drainag
delay
system
manifest
protract
circumst
effus
persist
microbi
etiolog
unknown
import
rememb
even
optim
antibiot
therapi
fever
anorexia
toxic
due
prolong
inflammatori
respons
addit
chang
appropri
select
antibiot
therapi
avoid
surgic
intervent
thoracentesi
recommend
reliev
moder
larg
effus
defin
fluid
layer
cm
later
decubitu
radiograph
opacifi
one
fourth
hemithroax
therapeut
approach
moderates
nonlocul
parapneumon
effus
associ
respiratori
compromis
slowli
drain
mlkg
send
fluid
microbiolog
studi
begin
empir
antibiot
therapi
intraven
import
drain
fluid
rapidli
reexpans
pulmonari
edema
occur
caus
increas
morbid
even
mortal
cours
observ
hour
mani
patient
improv
patient
improv
worsen
ultrasonographi
perform
determin
extent
reaccumul
fluid
reaccumul
continu
drainag
requir
antibiot
regimen
reconsid
patient
larg
effus
patient
respiratori
compromis
chest
tube
place
soon
possibl
continu
drainag
small
bore
chest
tube
prefer
patient
comfort
associ
shorter
hospit
stay
found
superior
surgic
stiff
drain
two
studi
chest
radiographi
repeat
verifi
chest
tube
placement
exclud
develop
pneumothorax
placement
complic
chest
tube
placement
includ
bleed
infect
exit
site
persist
atelectasi
develop
bronchopleur
fistula
rare
lacer
lung
locul
complex
parapneumon
effus
empyema
usual
requir
aggress
manag
optim
manag
remain
controversi
accord
british
thorac
societi
american
pediatr
surgic
associ
guidelin
medic
therapi
chemic
debrid
fibrinolysi
consid
initi
therapi
choic
follow
videoassist
thorac
surgeri
vat
patient
heavi
seed
pulmonari
circul
highgrad
bacteremia
lead
lung
abscess
pulmonari
infarct
associ
septic
embol
circumst
usual
lead
multipl
abscess
unilater
bilater
chronic
airway
diseas
cystic
fibrosi
congenit
ciliari
dysfunct
bronchiectasi
predispos
lung
abscess
inherit
abnorm
humor
cellular
immun
respons
chronic
granulomat
diseas
hyperigm
syndrom
permit
persist
certain
pathogen
result
abscess
format
clinic
manifest
necrot
pneumonia
similar
usual
sever
nonnecrot
pneumonia
due
bacteria
evolut
necrot
pneumonia
abscess
frequent
insidi
lung
abscess
aspir
usual
manifest
week
event
prolong
fever
toxic
appear
persist
hypoxia
despit
appropri
antimicrobi
therapi
characterist
fever
common
sign
patient
lung
abscess
cough
dyspnea
sputum
product
present
approxim
one
half
patient
cough
usual
nonproduct
spontan
ruptur
abscess
bronchu
massiv
product
hemoptysi
seen
necrot
pneumonia
older
children
may
report
chest
pain
without
radiat
symptom
nonspecif
includ
rhinorrhea
sore
throat
lymphadenopathi
decreas
appetit
irrit
malais
lethargi
physic
find
also
nonspecif
unless
accompani
pleural
fluid
differenti
diagnosi
lung
abscess
includ
common
necrot
bacteri
infect
well
tuberculosi
nocardiosi
fungal
infect
melioidosi
paragonimiasi
ameb
abscess
certain
noninfecti
diseas
malign
sarcoidosi
pulmonari
infarct
produc
lesion
mimic
abscess
chest
radiograph
chest
radiograph
obtain
child
whose
symptom
respond
appropri
antibiot
treatment
fig
initi
find
usual
irregular
cavitari
lesion
without
thick
wall
airfluid
level
adjac
segment
lobar
lung
infiltr
without
promin
hilar
adenopathi
multilobar
involv
seen
septa
lung
abscess
bronchopleur
fistula
lung
abscess
usual
outcom
wide
variabl
pathogen
process
consequ
necrot
pneumonia
local
infect
aspir
heavili
infect
mouth
secret
sometim
along
foreign
bodi
focal
infect
lung
occur
highgrad
bacteremia
result
infarct
septic
emboli
distant
site
complic
subacut
chronic
airway
infect
seen
late
result
cystic
fibrosi
prolong
intub
nosocomi
pneumonia
immunocompromis
host
bacteria
fungi
invad
vessel
wall
lead
subsequ
lung
infarct
necrot
pneumonia
see
chapter
communityacquir
bacteri
pneumonia
result
necrosi
parenchyma
often
discov
chest
radiographi
increasingli
ct
perform
child
prolong
fever
ill
appear
caus
pathogen
identifi
mani
case
detect
pneumonia
common
less
commonli
aureu
especi
camrsa
pyogen
especi
influenza
ill
streptococci
lancefield
group
c
g
streptococc
speci
caus
pneumatocel
complic
pneumonia
aureu
pneumonia
latter
lead
abscess
format
rare
sever
pneumonia
pneumonia
accompani
abscess
format
pneumonia
follow
aspir
oropharyng
flora
regurgit
stomach
content
obstruct
volatil
fatti
acid
produc
anaerob
bacteria
particularli
prone
caus
necrosi
abscess
aspir
pneumonia
lung
abscess
empyema
mix
infect
predomin
anaerob
bacteria
isol
peptostreptococcu
fusobacterium
prevotella
melaninogenica
porphyromona
spp
veillonella
may
like
isol
children
prior
surgeri
malign
corticosteroid
therapi
aspir
foreign
bodi
immunodefici
singl
multipl
lung
abscess
usual
due
aureu
infect
result
rightsid
endocard
sever
septicemia
distant
osteoarticular
deep
muscl
infect
thrombosi
necrot
pneumonia
lung
abscess
also
follow
endovascular
infect
phlebothrombosi
larg
vein
neck
lemierr
syndrom
fusobacterium
necrophorum
common
pathogen
aureu
streptococci
streptococcu
anginosu
group
actinomyc
spp
mold
caus
lung
abscess
intub
infant
children
usual
due
hospitalassoci
pathogen
abscess
develop
later
stage
cystic
fibrosi
secondari
chronic
bronchiectasi
case
aureu
p
aeruginosa
atyp
mycobacteria
consid
pathogenesi
necrot
pneumonia
consequ
sever
inflamm
confin
cluster
alveoli
lobe
result
signific
parenchym
damag
tissu
necrosi
abscess
format
follow
even
treatment
adequ
frequent
treatment
delay
inadequ
aspir
obstruct
airway
predispos
polymicrobi
anaerob
lung
abscess
risk
factor
includ
decreas
level
conscious
due
neurolog
diseas
anesthesia
alcohol
drug
surgic
instrument
neuromuscular
disord
depress
gag
reflex
esophag
abnorm
gastroesophag
reflux
prolong
endotrach
intub
poor
dental
hygien
periodont
infect
increas
densiti
anaerob
predispos
lung
abscess
adolesc
impair
phagocyt
respons
seen
neutropen
patient
viral
infect
influenza
measl
vzv
also
predispos
complic
pneumonia
aspir
acid
content
stomach
caus
chemic
injuri
lung
tissu
locat
abscess
favor
middl
right
lower
lobe
patient
aspir
erect
favor
posterior
upper
lower
lobe
supin
patient
abnorm
drainag
occur
congenit
pulmonari
sequestr
lobar
emphysema
pneumatocel
format
predispos
abscess
format
experiment
studi
anim
show
timelin
aspir
pneumonia
lung
abscess
least
week
figur
anaerob
pleural
empyema
girl
came
medic
attent
histori
abdomin
pain
tired
constip
histori
aspir
event
fever
respiratori
distress
cough
radiograph
obtain
acut
respiratori
event
evalu
constip
note
complet
opacif
left
hemithorax
sever
shift
heart
trachea
right
three
liter
putrid
pu
drain
reveal
left
lower
lobe
abscess
gram
stain
cultur
reveal
polymicrobi
anaerob
facult
oropharyng
flora
courtesi
e
n
faerber
long
st
christoph
hospit
children
philadelphia
pa
vancomycin
altern
patient
allergi
clindamycin
resist
aureu
preval
antistaphylococc
medic
linezolid
could
use
case
allergi
poor
respons
vancomycin
clindamycin
combin
therapi
ticarcillin
piperacillin
inhibitor
eg
tazobactam
without
aminoglycosid
may
consid
necrot
pneumonia
follow
aspir
hospit
child
child
enterobacteriacea
eg
e
coli
klebsiella
spp
p
aeruginosa
infect
suspect
identifi
percutan
lung
aspir
metronidazol
would
effect
treatment
anaerob
lung
abscess
aspir
use
alon
without
agent
activ
aerob
microaerophil
streptococci
necrot
pneumonia
abscess
frequent
complic
parapneumon
effus
benefit
percutan
drainag
invas
procedur
depend
size
clinic
factor
previous
percutan
drainag
abscess
often
complic
develop
bronchopleur
fistula
expect
good
outcom
medic
therapi
percutan
drainag
consid
patient
poor
respons
day
initi
therapi
abscess
cm
diamet
presenc
mediastin
shift
abscess
result
ventil
depend
surgic
wedg
resect
lobectomi
rare
requir
reserv
case
medic
manag
drainag
fail
bronchiectasi
occur
case
necrot
pneumonia
otherwis
healthi
children
resolv
antibiot
treatment
alon
similarli
lung
abscess
resolv
antibiot
therapi
alon
provid
associ
bronchial
obstruct
underli
lung
diseas
cystic
fibrosi
fever
persist
averag
day
despit
appropri
therapi
complic
due
lung
abscess
rare
develop
countri
otherwis
healthi
host
could
includ
intracavitari
hemorrhag
hemoptysi
spillag
abscess
spread
infect
part
lung
empyema
bronchopleur
fistula
septicemia
cerebr
abscess
siadh
author
acknowledg
previou
contribut
denni
murray
chapter
refer
avail
onlin
wwwexpertconsultcom
patient
underli
immun
dysfunct
septic
embol
chest
radiographi
may
diagnost
initi
approxim
case
one
studi
case
abscess
locat
right
lower
lobe
left
lower
lobe
right
upper
lobe
left
upper
lobe
ct
sensit
plain
radiographi
often
use
defin
extent
diseas
underli
anomali
presenc
absenc
foreign
bodi
fig
endobronchi
obstruct
distinguish
parenchym
abscess
airfluid
level
pleural
space
ultrasonographi
use
color
doppler
power
diagnost
tool
differenti
fluidfil
lung
abscess
empyema
advantag
greater
conveni
lower
cost
avoid
radiat
bronchoscopi
may
therapeut
mean
facilit
remov
foreign
bodi
promot
drainag
purul
fluid
bronchoscop
specimen
cultur
grew
organ
later
recov
lung
abscess
cultur
sputum
bal
blood
limit
diagnost
valu
compar
cultur
direct
lung
aspir
one
studi
specimen
obtain
transthorac
aspir
yield
pathogen
despit
prior
receipt
antibiot
compar
sputum
cultur
blood
bal
cultur
ultrasoundguid
transthorac
aspir
techniqu
use
success
obtain
specimen
diagnosi
drain
lung
abscess
prematur
infant
potenti
risk
spillag
contamin
fluid
pleural
space
ultrasoundor
ctguid
transthorac
aspir
procedur
reserv
patient
improv
clinic
antibiot
therapi
larg
abscess
must
drain
prolong
antibiot
administr
mainstay
therapi
necrot
pneumonia
lung
abscess
durat
therapi
base
clinic
respons
usual
week
least
week
patient
becom
afebril
clinic
improv
case
parenter
therapi
initi
two
random
clinic
trial
adult
found
clindamycin
superior
penicillin
treatment
anaerob
lung
abscess
random
clinic
trial
treatment
children
aspir
pneumonia
found
differ
two
drug
ampicillinsulbactam
excel
spectrum
activ
organ
aspir
lung
abscess
parenter
clindamycin
appropri
empir
therapi
children
complic
lung
infect
possibl
due
aureu
camrsa
